<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005071A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005071</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14017186</doc-number><date>20130903</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>G</section><class>01</class><subclass>N</subclass><main-group>33</main-group><subgroup>68</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>G</section><class>01</class><subclass>N</subclass><main-group>33</main-group><subgroup>6863</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>506  9</main-classification></classification-national><invention-title id="d0e43">Method of Using Cytokine Assays to Diagnose, Treat, and Evaluate Inflammatory Disease</invention-title><us-related-documents><division><relation><parent-doc><document-id><country>US</country><doc-number>13467680</doc-number><date>20120509</date></document-id><parent-status>PENDING</parent-status></parent-doc><child-doc><document-id><country>US</country><doc-number>14017186</doc-number></document-id></child-doc></relation></division><continuation><relation><parent-doc><document-id><country>US</country><doc-number>10514701</doc-number><date>20050913</date></document-id><parent-status>ABANDONED</parent-status><parent-pct-document><document-id><country>WO</country><doc-number>PCT/US2004/030059</doc-number><date>20040915</date></document-id></parent-pct-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13467680</doc-number></document-id></child-doc></relation></continuation><us-provisional-application><document-id><country>US</country><doc-number>60503131</doc-number><date>20030915</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Oklahoma Medical Research Foundation</orgname><address><city>Oklahoma City</city><state>OK</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>The Board of Regents of the University of Oklahoma</orgname><address><city>Norman</city><state>OK</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Chappell</last-name><first-name>Cherie M.</first-name><address><city>Annapolis</city><state>MD</state><country>US</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Centola</last-name><first-name>Michael B.</first-name><address><city>Oklahoma City</city><state>OK</state><country>US</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Alex</last-name><first-name>Philip J.</first-name><address><city>Edmond</city><state>OK</state><country>US</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Hensley</last-name><first-name>Kenneth</first-name><address><city>Oklahoma City</city><state>OK</state><country>US</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Oklahoma Medical Research Foundation</orgname><role>02</role><address><city>Oklahoma City</city><state>OK</state><country>US</country></address></addressbook></assignee><assignee><addressbook><orgname>The Board of Regents of the University of Oklahoma</orgname><role>02</role><address><city>Norman</city><state>OK</state><country>US</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The invention provides methods for diagnosing, treating, or evaluating inflammatory and autoimmune diseases by sampling peripheral blood, serum, plasma, tissue, cerebrospinal fluid, or other bodily fluids from a human subject having a suspected diagnosis. The sample is analyzed for the presence and amount of certain cytokines, which provides the diagnosis, prognosis or evaluation of therapeutic response.</p></abstract></us-patent-application>